Cervical Dystonia Market is segmented By Treatment Type (Botulinum Toxin Injections, Oral Medications, Surgical Procedures, Physical Therapy), By Dist....
Market Size in USD
CAGR6%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 6% |
Market Concentration | High |
Major Players | Allergan plc, Ipsen Pharma, Merz Pharma GmbH & Co. KGaA, Lundbeck A/S, Revance Therapeutics, Inc. |
The cervical dystonia market is estimated to be valued at USD 265.1 Mn in 2024 and is expected to reach USD 400.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 6% from 2024 to 2031. Cervical dystonia is a neurological movement disorder characterized by involuntary muscle contractions in the neck and acute to moderate chronic pain, leading to aberrant head positioning or Turnbulls' disease.